Drawing for MUGARD

USPTO serial 85116721

MUGARD

Reviewed by CopyMark Law Group

Reg. 3950832Status 710
Filing date
Status date
Registration date
Apr 26, 2011
Examiner
TENG, SIMON
Law office
TMEG LAW OFFICE 105

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MUGARD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Katherine P. Califa

Katherine P. Califa Foley & Lardner LLP3000 K Street, N.W.Sixth FloorWashington, DC 20007-5109

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; ] Pharmaceutical preparations for the treatment and prevention of oral [ and esophageal ] mucositis [ ; drug delivery agents consisting of compounds that facilitate delivery of a wide range of active pharmaceuticals to the oral mucosa ]SECTION 8 - CANCELLEDDec 25, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 19, 2021CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Feb 24, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 10, 2020ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 26, 2020REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jan 22, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 19, 2016NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 19, 2016C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 19, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 10, 2016E815TEAS SECTION 8 & 15 RECEIVED—
Apr 26, 2016REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 8, 2015ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 26, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 26, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 18, 2015ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 26, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 8, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 8, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 6, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 6, 2011ALIEASSIGNED TO LIE—
Dec 9, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 9, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Dec 9, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 9, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 9, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 8, 2010DOCKASSIGNED TO EXAMINER—
Aug 31, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 30, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance